Business Wire

Helena Announces Strategic Partnership With Energy Vault

20.7.2021 15:00:00 EEST | Business Wire | Press release

Share

Global problem-solving organization Helena and Energy Vault, the creator of renewable energy storage products that are transforming the world’s approach to utility-scale energy storage for grid resiliency, today announced a strategic partnership to identify additional opportunities for Energy Vault’s breakthrough waste remediation technologies as the company begins deployment of its innovative energy storage system worldwide.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210720005330/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Energy Vault Commercial Demonstration Unit - Arbedo-Castione, Switzerland. (Photo: Business Wire)

While supporting Energy Vault’s expansion through Helena’s vast network, the strategic partnership will focus on accelerating adoption by global energy providers of the company’s transformative technology, in particular its advanced material remediation innovations. The unique application of material science to the main energy storage medium – the composite blocks – enables the use of alternative materials to replace environmentally unfriendly substances like concrete, which accounts for 7-8% of greenhouse gas emissions. In addition, the technology can accommodate the recycling of various pre-existing waste materials, which in return helps large utility and industrial companies transform financial and environmental liabilities into infrastructure assets to support their transition to a fully circular economic approach. For example, coal ash waste and retired wind turbine blades can be re-directed from landfills into its custom-made composite blocks that anchor the company’s gravity-powered systems. By maximizing the use of locally sourced soil, sand and waste materials, including outputs from fossil fuel production, Energy Vault’s supply chain design reduces the impact of GHGs from the transport sector while increasing jobs for local economies, the end result being an end-of-life solution for materials that are difficult to break down and can have negative environmental consequences. This beneficial reuse eliminates waste and enables the continual use of local resources within the framework of a circular economy.

This work will build upon the technology and commercial partnership that it previously announced in 2019 with CEMEX Research Group, a subsidiary of global building materials company CEMEX, and supports the collaboration Energy Vault most recently announced earlier this month with leading global energy powerhouse Enel Green Power.

As part of the partnership, which began in late 2020, Helena also announced that it completed a $20 million investment in Energy Vault. Helena’s investment and partnership with Energy Vault is conducted through Helena’s for-profit arm, Helena Special Investments, which operates projects that implement solutions to societal problems through for-profit means. Helena has joined other investors including Saudi Aramco Energy Ventures, SoftBank Vision Fund, CEMEX Ventures, Idealab, and Neotribe Ventures. As part of its investment, Helena Founder and CEO Henry Elkus joined Energy Vault’s board of directors.

"Our job at Helena is to identify and implement solutions to the critical global problems of the next 50 years. It doesn’t get much more critical than radically improving energy storage. It is both a short-term solution to the problems we have seen recently in areas like Texas and a long-term necessity for the world to sustainably transition away from fossil fuels. We believe Energy Vault will play a fundamental role in furthering that transition,” said Helena Founder and CEO Henry Elkus. “We are also supporting Energy Vault’s strategy in addressing another essential problem – remediating waste. The company’s ability to use massive quantities of waste material to construct its systems only makes the impact more real and the business case more viable while also providing utilities a streamlined method to transition out of fossil fuel-based energy production and recycle legacy assets.”

“We are thrilled to partner with Helena in pursuit of our shared mission and mutual passion in accelerating the decarbonization of our planet,” said Robert Piconi, CEO and Co-Founder, Energy Vault. “Given Helena’s focus in taking on the most significant global challenges – in this case the global transition to clean energy production – we are grateful to have them alongside us as both strategic partner and investor. Helena and its global network are already making an impact toward our technology adoption, and our continued work together will help the world to take a vital step towards combating the negative impacts of climate change.”

About Helena

Helena is a global problem-solving organization. Through Helena Projects, Helena seeks to implement solutions to critical societal problems. Since its founding in 2015, Helena Projects have included: America In One Room, which garnered the attention of President Barack Obama and The New York Times for one of the most significant political experiments in U.S. history; Factory in the Sky, which supported the development and construction of the world’s first carbon capture factory; Shield, which worked to protect the electrical grid from foreign and domestic threats; and most recently The Covid Project, which supplied tens of millions units of medical supplies and personal protective equipment to frontline responders during the COVID-19 pandemic. To learn more about Helena, visit helena.org.

About Energy Vault

Energy Vault is the creator of renewable energy storage products that are transforming the world’s approach to utility-scale energy storage for grid resiliency. Applying conventional physics fundamentals of gravity and potential energy, the system combines an innovative crane design that lifts specially designed, massive composite blocks with a proprietary, cloud-based software platform which orchestrates the storage and discharge of electricity. Utilizing 100% eco-friendly materials at unprecedented economics, Energy Vault is accelerating the shift to a fully renewable world.

For more information about Energy Vault, please visit energyvault.com and @EnergyVaultInc.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Helena Media
Catherine Pope
1.855.438.3553
helena@ellecomm.com

Energy Vault Media
media@energyvault.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release

NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release

Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim

Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 14:00:00 EEST | Press release

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo

IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 13:50:00 EEST | Press release

IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio transformation and is expected to strengthen the company’s focus on its innovation-driven businesses: Taste, Scent, and Health & Biosciences. Following the transaction, IFF will be

BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 13:00:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 patients, underscoring consistent effectiveness and safety in clinical practice. Additionally, BEQALZI™ (sonrotoclax), which was recently approved by the U.S. Food and Drug Administration, and its development in combination with BRUKINSA (ZS) highlight the potential for next-generation, time-limited treatment approaches in CLL. Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology, BeOne Medicines, said: “CLL is a disease patients live with

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye